Evidence map›Paper›PMID 31683599›Full record

ArticleMolecules (Basel, Switzerland)2019

Preparation of Progesterone Co-Crystals Based on Crystal Engineering Strategies.

Huahui Zeng, Jing Xiong, Zhuang Zhao, Jingyi Qiao, Duanjie Xu, Mingsan Miao, Lan He, Xiangxiang Wu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Huahui ZengAcademy of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450046, Henan, China. hhzeng@hactcm.edu.cn.
Jing XiongNational Institutes for Food and Drug Control, Beijing 102629, China. xiongjing@nifdc.org.cn.
Zhuang ZhaoGuangxi Institute for Food and Drug Control, Nanning 530021, Guangxi, China. keypersonal_1@sina.com.
Jingyi QiaoAcademy of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450046, Henan, China. qiaojingyi618@126.com.ORCID 0000-0003-0462-7030
Duanjie XuAcademy of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450046, Henan, China. xuduanjie123@163.com.
Mingsan MiaoAcademy of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450046, Henan, China. miaomingsan@163.com.
Lan HeNational Institutes for Food and Drug Control, Beijing 102629, China. helan1961@aliyun.com.
Xiangxiang WuAcademy of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450046, Henan, China. wuxx-415@126.com.
First Affiliated Hospital of Henan University · CNNational Institutes for Food and Drug Control · CN

Funding

National Natural Science Foundation of China 21601053, U1604185Natural Science Foundation of Guangxi Province 2017X4Natural Science Foundation of Henan Province 20HASTIT050,182102410012, 192102310440
6 · The paper itself

Abstract

Three co-formers of 2-chloro-4-nitroaniline (CNA), 2,5-dihydroxybenzoic acid (DHB), and 4,4'-biphenol (DOD) were selected to prepare the co-crystal of progesterone (PROG) based on crystal engineering strategies. These co-crystals were successfully obtained via slow evaporation from different solutions and were characterized by single-crystal X-ray diffraction spectroscopy, powder X-ray diffraction, IR spectroscopy, and differential scanning calorimetry. Different binding networks were observed in the co-crystal structures of PROG. The PROG-CNA co-crystal had the fastest rates and highest concentrations of PROG in PBS solution compared with PROG or other co-crystals in the dissolution experiments. This might be attributable to more stable and abundant interactions between the PROG and CNA molecules. Our investigations provide positive support for the selection of suitable co-formers using crystal engineering strategies.

Indexed as

Aniline CompoundsCalorimetry, Differential ScanningChromatography, High Pressure LiquidCrystallizationCrystallography, X-RayGentisatesHydrogen BondingModels, MolecularProgesteroneSpectroscopy, Fourier Transform Infrared2,5-dihydroxybenzoic acid2-chloro-4-nitroanilineAniline CompoundsGentisatesProgesteroneco-crystalscrystal engineeringprogesterone

Identifiers

PMID31683599
PMCPMC6864860
OpenAlexW2982384985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.